Effects of a 5:2 Diet on Weight Loss and Cardiovascular Risk Factors in Obesity

July 12, 2017 updated by: Tine Mejlbo Sundfør, Oslo University Hospital
A randomized clinical trial comparing the effect on weight reduction and cardiometabolic risk factors of intermittent energy restriction and a isocaloric continuous energy restriction in obese subjects.

Study Overview

Detailed Description

Background: The optimal diet for treating obesity and cardiovascular disease (CVD) risk is still not clarified. Could a five plus two diet, a form of intermittent energy restriction lead to good adherence, similar weight loss and reduction in CVD risk factors as a isocaloric continuous energy restrictions in obese subjects.

Methods: The study is a randomized controlled clinical trial in 120 men and women between 21 to 70 years with BMI (BMI 30-45 kg/m2), stable weight within ±3 kg last 3 months and 1 additional metabolic syndrome risk component.

Dietary intervention: Randomization will be to one of two diet groups. Participants in the intervention group will follow av 5:2 diet and participants in the control group will follow an isocaloric continuous energy restriction.

Primary research question: Compare the effect on weight reduction of intermittent energy restriction and a isocaloric continuous energy restriction in obese subjects? Secondary research questions Compare the effect of intermittent energy restriction and an isocaloric continuous energy restriction on cardiometabolic risk factors and tolerability and safety in obese subjects. The project consist of to randomized controlled clinical trials.

Study Type

Interventional

Enrollment (Actual)

112

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oslo, Norway, 0424
        • Oslo Universitetssykehus, Ullevål, avdeling for preventiv kardiologi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men and women between 21 to 70 years.
  • BMI (BMI 30-45 kg/m2).
  • stable weight within ±3 kg last 3 months.
  • 1 additional metabolic syndrome risk component.

Exclusion Criteria:

  • Diabetes if treated with insulin or incretin analogues.
  • History of bariatric surgery.
  • Use of antiobesity drugs or supplements.
  • Eating disorder.
  • Psychiatric illness that contributes to difficulties with study procedures.
  • Alcohol or drug abuse.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: intermittent energy restriction
dietary intervention, intermittent energy restriction. Participants in the experimental group will follow av 5:2 diet and consume a very low calorie diet providing 400 (females) to 600 (males) calories of energy to days a week and for an average male participant, this will reduce energy intake approximately 22%.
Randomized clinical trial
Active Comparator: continuous energy restriction
dietary intervention, continuous energy restrictions.Participants in the active comparator group will be asked to reduce daily energy intake by 22-23%

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
weight reduction
Time Frame: 1 year
Compare the effect on weight reduction of intermittent energy restriction and a isocaloric continuous energy restriction in obese subjects
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cholesterol
Time Frame: 1 year
Compare the effect of intermittent energy restriction and isocaloric contiuous energy restriction on cholesterol
1 year
adverse events
Time Frame: 1 year
Compare the effect of intermittent energy restriction and an isocaloric continuous energy restriction on cardiometabolic risk factors and tolerability and safety in obese subjects
1 year
blood pressure
Time Frame: 1 year
Compare the effect of intermittent energy restriction and isocaloric continuous energy restriction on blood pressure
1 year
fasting glucose
Time Frame: 1 year
Compare the effect of intermittent energy restriction and isocaloric continuous energy restriction on fasting glucose
1 year
triglycerides
Time Frame: 1 year
Compare the effect of intermittent energy restriction and isocaloric contiuous energy restriction on fasting triglycerides
1 year
HbA1c
Time Frame: 1 year
Compare the effect of intermittent energy restriction and isocaloric contiuous energy restriction on HbA1c
1 year
C-reactive protein (CRP)
Time Frame: 1 year
Compare the effect of intermittent energy restriction and isocaloric contiuous energy restriction on CRP
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Actual)

April 25, 2017

Study Completion (Actual)

April 25, 2017

Study Registration Dates

First Submitted

June 3, 2015

First Submitted That Met QC Criteria

June 22, 2015

First Posted (Estimate)

June 24, 2015

Study Record Updates

Last Update Posted (Actual)

July 17, 2017

Last Update Submitted That Met QC Criteria

July 12, 2017

Last Verified

September 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 2014/1702 (REK)
  • 1702 (REK (The national commitees for research ethics in Norway))

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on dietary intervention intermittent energy restriction

Subscribe